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How cells regulate the distribution of a limited pool of actin between two competing structures has long been
amystery. Complementary studies fromSuarez et al. (2015) and Rotty et al. (2015) now show that profilin con-
trols the partitioning of actin monomers between competing actin networks assembled by Arp2/3 complex
and formins or Ena/VASP.A central question in biological studies is
how the sizes of different subcellular
structures are controlled when they are
assembled competitively from a finite
pool of common building blocks (Hyman
et al., 2014). For example, in eukaryotic
cells, diverse architectures of filamentous
actin must be assembled side by side
from a limited pool of actin monomers
within a shared cytoplasm (Michelot and
Drubin, 2011). These actin networks
include parallel arrangements of filaments
such as those found in filopodia, antipar-
allel arrangements such as those in stress
fibers and contractile rings, and branched
filament arrays such as those at the
leading edge and sites of endocytosis.
The formation of these different networks
is initiated and maintained by distinct
sets of actin nucleation and elongation
machineries. For instance, the Arp2/3
complex nucleates formation of branched
actin filament networks, whereas formins,
Ena/VASP, and other nucleators build un-
branched, linear arrays. This dichotomy is
on full display in budding and fission
yeast, where there are only twomain actin
structures, patches and cables, which
are assembled separately by the Arp2/3
complex and by formins, respectively. In
mammalian cells, the situation is more
complex, yet there is clear evidence that
Arp2/3 complex and formins each play
lead roles in the assembly of specific actin
structures.
How yeast and mammalian cells regu-
late the distribution of the limited pool of
actin monomers between different nucle-
ation systems has been an open question
for some time. Recent work in yeast from
the Kovar lab has shown that acute phar-
macological disruption of the Arp2/3
complex leads to actin cable overgrowth,and, reciprocally, pharmacological or
genetic disruption of formins leads to
overgrowth of patches (Burke et al.,
2014). Now two new studies identify pro-
filin as the molecular ‘‘gatekeeper’’ con-
trolling this homeostatic balance between
different nucleation systems and demon-
strate that profilin ‘‘steers’’ actin mono-
mers toward formins and Ena/VASP pro-
teins, enabling them to compete against
the more-abundant Arp2/3 complex for a
limited pool of actin (Figure 1).
Profilin is an abundant and evolution-
arily conserved actin monomer-binding
protein found in all eukaryotic systems
(Blanchoin et al., 2014). It suppresses
spontaneous actin polymerization and
blocks monomer addition onto pointed
ends of filaments but freely allows addi-
tion to barbed ends. It has two well-char-
acterized binding surfaces, one that inter-
acts with actin monomers and one that
interacts with specific proline-rich motifs
present in proteins such as formins and
Ena/VASP (Blanchoin et al., 2014). Esti-
mated cellular concentrations suggest
that the yeast Arp2/3 complex outnum-
bers active formins by 15-fold (Suarez
et al., 2015). Based on cell staining, it is
likely that Ena/VASP proteins are also far
less abundant than the Arp2/3 complex.
This raises the question of how formins
and Ena/VASP compete with the Arp2/3
complex to build actin structures. Given
that profilin has been shown to play a crit-
ical role in vitro in enabling formins to
accelerate actin filament polymerization
(Kovar et al., 2006), and that it has been
shown to be critical in vivo for formin-
dependent actin assembly (Chang et al.,
1997), the investigators in both studies
asked whether profilin maintains the bal-
ance between formin- and Arp2/3 com-Developmental Cellplex-assembled actin cellular structures
and gives formins a fighting chance to
get their share of the actin.
To put this question to the test, Rotty
and colleagues (2015) raised and lowered
profilin levels in both wild-type and Arp2/3
complex-deficient mammalian fibroblasts
and then quantitatively assessed cell
morphology and filamentous actin levels.
Their analysis showed that cells geneti-
cally deficient in Arp2/3 complex had
wild-type levels of total actin but lacked
lamellipodia and showed defective pro-
trusion dynamics. The Arp2/3 complex-
deficient cells also exhibited an over-
growth of unbranched actin filament
arrays, and this phenotype could be
suppressed by further depletion of profi-
lin. Overproduction of profilin had oppo-
site effects, i.e., enhancing linear actin
arrays in both the wild-type and Arp2/3
complex-deficient cells. In an in vitro
reconstitution system, exogenous profilin
inhibited actin nucleation by Arp2/3 com-
plex and N-WASP VCA domain, demon-
strating that profilin not only promotes
formin- and Ena/VASP-dependent actin
assembly, as was shown previously, but
also inhibits Arp2/3 complex-mediated
actin assembly. Interestingly, in cells lack-
ing the Arp2/3 complex, treatment with
the formin inhibitor SMIFH2 did not sup-
press overgrowth of the unbranched actin
structures, suggesting either that profilin
works through Ena/VASP or other pro-
teins to produce these linear actin struc-
tures or that the anti-formin compound
does not reach all classes of formins.
In the other study, Suarez and col-
leagues asked whether profilin regulates
the competition between formins and
the Arp2/3 complex in fission yeast. The
authors used genetic approaches to32, January 12, 2015 ª2015 Elsevier Inc. 5
Figure 1. Model Depicting Profilin as the Molecular Gatekeeper of
Actin Building Block Distribution
In cells, only a fraction of the actin monomer pool is bound by profilin. Profilin-
actin subunits are used preferentially by formins and Ena/VASP to build un-
branched (linear) actin structures, while free actin subunits are used more
favorably by the Arp2/3 complex and its nucleation-promoting factors to
construct branched filament networks. Thus, higher levels of profilin tip the
balance toward formin- and Ena/VASP-mediated actin assembly.
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Previewsoverexpress or reduce actin
and profilin levels, employed
the small-molecule-inhibitor
CK666 to inactivate the
Arp2/3 complex, and devel-
oped in vitro competition as-
says for actin assembly
(Suarez et al., 2015). They
found that the ratio of profilin
to monomeric actin was
critical for maintaining the
normal balance between for-
mation of actin cables and
patches. Further, they recon-
stituted in vitro this competi-
tion between Arp2/3 complex
and formins and showed that
modulating the level of pro-
filin could tune the balance
between these two nucle-
ation systems. Increasing
levels of profilin shifted the
distribution of actin assembly
toward formins. Further, even
in the absence of formins,
profilin inhibited actin nucle-
ation by the Arp2/3 complex.
In addition, both Suarez et al.
(2015) and Rotty et al. (2015)
used mutants of profilin
defective at its two binding
surfaces to probe themecha-nism. In both systems they found that the
actin monomer-binding surface of profilin
is required for its ability to suppress
Arp2/3 complex-mediated actin assem-
bly, while the polyproline-binding surface
was required for enhancement of formin-
mediated actin assembly.
Together, the two studies define profilin
as a key factor in regulating the balance
between different types of cellular actin
networksproducedbydifferent nucleation
systems. This in turn suggests that
homeostasis in different cell types and or-
ganisms may be controlled by altering
expression levels of profilin or by express-
ing specific isoforms of profilin that
interact preferentiallywith specific formins
and Ena/VASP proteins. In future studies,
itwill be important to determinemechanis-6 Developmental Cell 32, January 12, 2015 ªtically how profilin is inhibiting the Arp2/3
complex; perhaps this involves the previ-
ously described profilin-binding site on
Arp2 (Mullins et al., 1998) and/or competi-
tion with specific nucleation-promoting
factors (NPFs) of Arp2/3 complex. It will
also be important to determine whether
profilin inhibits nucleation by Arp2/3 com-
plex using full-lengthNPFs, because in the
present studies only small VCA fragments
of N-WASP and S. pombe WASP/Wsp1p
were used. This may be relevant because
a previous study found that profilin inhibits
S. cerevisiae Arp2/3 complex-mediated
actin assembly stimulated by VCAdomain
but not by full-length Las17/WASP (Rodal
et al., 2003). In addition, it will be important
to consider how lipid inactivationof profilin
might favor Arp2/3 complex-mediated2015 Elsevier Inc.actin assembly in specific
locations of cells while allow-
ing more global inhibition of
Arp2/3 complex-mediated
nucleation elsewhere in the
cell. Finally, it will be impor-
tant to quantify levels of free
profilin, profilin-bound actin
monomers, and free actin
monomers in cells. With these
numbers, a more complete
understanding of the re-
source-distribution mecha-
nism can be gained.ACKNOWLEDGMENTS
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